ArticleCurrent microbiology2026
Integrated Screening and Antifungal Potential of Microalgae Extracts Against Botrytis californica.
Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Increasing agricultural productivity to meet the growing population's food requirements has now become the main focus of scientific and policy-driven research. But the intensive use of synthetic fungicides has caused potential harm to humans and the environment. Microalgae are gaining recognition as promising sources of bioactive compounds for sustainable agricultural applications. The comparative antifungal potential of different microalgae using various polar solvents, and the study of molecular docking between major antifungal compounds obtained from microalgal extracts and fungal targets, remain unexplored. Therefore, the present study focuses on the antifungal properties of two freshwater microalgal strains (Tetradesmus sp. PV683316 and Scenedesmus sp. PV683315) isolated from aquatic ecosystems of Uttarakhand, India, against Botrytis californica. Microalgal extracts were prepared in different solvents, i.e., methanol (TdME and ScME), ethanol (TdEE and ScEE), and acetone (TdAE and ScAE), and screened for antifungal activity via the poisoned food technique. Morphological changes in B. californica were studied using SEM treated with the ethanol extract of TdEE. A diverse set of bioactive compounds present in microalgal extracts was identified through GC-MS. In this study, TDEE (100 µL/mL) showed up to 82.60 ± 0.83% mycelial growth inhibition of B. californica as compared to other microalgal extracts prepared in different solvents. The study also revealed that TdEE reduced the formation of conidia and conidiophores of Botrytis californica. Major compounds detected in GC-MS analysis of TdEE were benzyl-diethyl-(2,6-xylylcarbamoylmethyl)ammonium benzoate (29.27%), benzenepropanoic acid, 3,5-bis(1,1-dimethylethyl)-4-hydroxy-, methyl ester (15.06%), lidocaine (14.81%), benzoic acid 4-ethoxy-ethyl (7.95%), 2,4-di-tert-butylphenol (5.26%), and 1-(4-Ethoxyphenyl)propan-1-ol (3.28%). These findings highlight the potential of microalgae as eco-friendly sources in sustainable agriculture as antifungal agents for crop protection.
Indexed as
Identifiers
42363955What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.